Navidea Biopharmaceuticals, Inc.

Robbins LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.

Robbins LLP is investigating whether certain officers and directors of Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) (“Navidea”) breached their fiduciary duties to shareholders. Navidea focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents.

Navidea shareholders who would like more information about their rights and potential remedies can complete the form below and we will contact you directly. You can also contact attorney Darnell R. Donahue at (800) 350-6003.

Send us a message for more information.

Skip to content